Dr. Kellie A. Sprague, MD

Dr. Sprague practices at MaineHealth Maine Medical Center in Portland, Maine, part of MaineHealth.

Dr. Sprague's NPI, 1942240585, was assigned on June 8, 2006. Dr. Sprague graduated from The Robert Larner, M.D. College of Medicine in 1991. Dr. Sprague holds Maine license MD24532.

Dr. Sprague's primary practice is MaineHealth Maine Medical Center, at 22 Bramhall St, Portland, ME 04102 in Cumberland County. The practice phone is (207) 662-0111.

Dr. Sprague's primary practice is MaineHealth Maine Medical Center in Portland, Maine, part of MaineHealth. Dr. Sprague is also affiliated with York Hospital. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Dr. Sprague to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sprague practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sprague's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Sprague is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Sprague's licenses on file in 3 states: Maine, New Hampshire and Massachusetts.

Dmand AI lists chronic anemia, chronic leukemia, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Sprague treats.

CMS data shows 305 Medicare services from Dr. Sprague across 4 procedure codes in 2024, for 109 Medicare patients. Medicare paid $27,828 for them. Every service was in an office.

CMS counts 109 Medicare patients who saw Dr. Sprague in 2024. The largest group is 65 to 74, with 49 patients. 68% of them have high cholesterol, and 62% have high blood pressure. 14% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sprague's median patient age at 72, with 50% women.

In 2024, Dr. Sprague wrote 563 Medicare Part D claims for 83 patients. 69% of them were for generic drugs. CMS names the drug for 347 of them, across 15 drugs with 11 or more claims each, at $2,727,909 in total drug cost. In 2023, CMS named 406 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Sprague for performance year 2024, reported through an alternative payment model (APM). Dr. Sprague accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 23 papers to Dr. Sprague, published from 2008 to 2020. 2018 was the busiest year, with 2. The most frequent topics are Graft vs Host Disease, Hematopoietic Stem Cell Transplantation and Antineoplastic Agents. Dr. Sprague has published most often in Blood. Dr. Sprague's most frequent co-authors are Andreas K. Klein, MD, Raymond L. Comenzo, MD and Kenneth David Miller, MD.

Dmand AI links Dr. Sprague to 13 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Immunoglobulin Light-chain Amyloidosis. ECOG-ACRIN Cancer Research Group sponsors the most, 2.

CMS Open Payments shows 15 general payments to Dr. Sprague from 11 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 44% of the total. Pfizer Inc. paid the most, $1,302.

Dmand AI lists 1 award for Dr. Sprague, most recently Boston Magazine in 2020.

Dr. Sprague graduated from The Robert Larner, M.D. College of Medicine in 1991. Dr. Sprague is a member of ASCO, ASH and American Society of Transplantation and Cellular Therapy.

Dr. Sprague is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.